FDA approves MedImmune’s nasal spray flu vaccine FluMist
The U.S. Food and Drug Administration has approved FluMist, a nasal spray flu vaccine by MedImmune LLC, for self-administration or caregiver-administration. This marks a significant development in the prevention of influenza, as FluMist becomes the first flu vaccine that does not require administration by a healthcare provider. The vaccine is approved for individuals aged 2 […]